Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice
- PMID: 20133926
- PMCID: PMC2891493
- DOI: 10.1164/rccm.200910-1485OC
Chronic cigarette smoke exposure generates pathogenic T cells capable of driving COPD-like disease in Rag2-/- mice
Abstract
Rationale: Pathogenic T cells drive, or sustain, a number of inflammatory diseases. Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease associated with the accumulation of activated T cells. We previously demonstrated that chronic cigarette smoke (CS) exposure causes oligoclonal expansion of lung CD4(+) T cells and CD8(+) T cells in a mouse model of COPD, thus implicating these cells in disease pathogenesis.
Objectives: To determine whether T cells are pathogenic in a CS-induced mouse model of COPD.
Methods: We transferred lung CD3(+) T cells from filtered air (FA)- and CS-exposed mice into Rag2(-/-) recipients. Endpoints associated with the COPD phenotype were then measured.
Measurements and main results: Here, we demonstrate that chronic CS exposure generates pathogenic T cells. Transfer of CD3(+) T cells from the lungs of CS-exposed mice into Rag2(-/-) recipients led to substantial pulmonary changes pathognomonic of COPD. These changes included monocyte/macrophage and neutrophil accumulation, increased expression of cytokines and chemokines, activation of proteases, apoptosis of alveolar epithelial cells, matrix degradation, and airspace enlargement reminiscent of emphysema.
Conclusions: These data formally demonstrate, for the first time, that chronic CS exposure leads to the generation of pathogenic T cells capable of inducing COPD-like disease in Rag2(-/-) mice. This report provides novel insights into COPD pathogenesis.
Figures








Similar articles
-
Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD.Am J Physiol Lung Cell Mol Physiol. 2014 Nov 1;307(9):L692-706. doi: 10.1152/ajplung.00092.2014. Epub 2014 Aug 15. Am J Physiol Lung Cell Mol Physiol. 2014. PMID: 25128521
-
Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice.J Immunol. 2006 Oct 1;177(7):4350-9. doi: 10.4049/jimmunol.177.7.4350. J Immunol. 2006. PMID: 16982869
-
Functional characterization of T cell populations in a mouse model of chronic obstructive pulmonary disease.J Immunol. 2013 Feb 1;190(3):1331-40. doi: 10.4049/jimmunol.1202442. Epub 2012 Dec 21. J Immunol. 2013. PMID: 23264660 Free PMC article.
-
Inflammatory cells and chronic obstructive pulmonary disease.Curr Drug Targets Inflamm Allergy. 2005 Dec;4(6):607-18. doi: 10.2174/156801005774912824. Curr Drug Targets Inflamm Allergy. 2005. PMID: 17305517 Review.
-
State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice.Proc Am Thorac Soc. 2006 Aug;3(6):494-8. doi: 10.1513/pats.200603-068MS. Proc Am Thorac Soc. 2006. PMID: 16921126 Review.
Cited by
-
Innate Immunity and Cell Surface Receptors in the Pathogenesis of COPD: Insights from Mouse Smoking Models.Int J Chron Obstruct Pulmon Dis. 2020 May 20;15:1143-1154. doi: 10.2147/COPD.S246219. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32547002 Free PMC article. Review.
-
Macrophages Inhibit Ciliary Protein Levels by Secreting BMP-2 Leading to Airway Epithelial Remodeling Under Cigarette Smoke Exposure.Front Mol Biosci. 2021 Apr 26;8:663987. doi: 10.3389/fmolb.2021.663987. eCollection 2021. Front Mol Biosci. 2021. PMID: 33981724 Free PMC article.
-
The missing link between smoking and COPD autoreactivity?Am J Respir Crit Care Med. 2011 Oct 1;184(7):747-9. doi: 10.1164/rccm.201107-1228ED. Am J Respir Crit Care Med. 2011. PMID: 21965008 Free PMC article. No abstract available.
-
Inhibitory effects of Stemona tuberosa on lung inflammation in a subacute cigarette smoke-induced mouse model.BMC Complement Altern Med. 2014 Dec 20;14:513. doi: 10.1186/1472-6882-14-513. BMC Complement Altern Med. 2014. PMID: 25528348 Free PMC article.
-
Pathogenesis of chronic obstructive pulmonary disease.J Clin Invest. 2012 Aug;122(8):2749-55. doi: 10.1172/JCI60324. Epub 2012 Aug 1. J Clin Invest. 2012. PMID: 22850885 Free PMC article. Review.
References
-
- Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009;360:2445–2454. - PubMed
-
- Aubry MC, Wright JL, Myers JL. The pathology of smoking-related lung diseases. Clin Chest Med 2000;21:11–35. - PubMed
-
- Ryu JH, Colby TV, Hartman TE, Vassallo R. Smoking-related interstitial lung diseases: a concise review. Eur Respir J 2001;17:122–132. - PubMed
-
- Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532–555. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials